Strides Pharma Science Limited has informed the Exchange about Copy of Newspaper Publication regarding Un-Audited Financial Results for the quarter and nine months ended December 31, 2025.
STAR · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Strides Pharma Science has informed the stock exchange that it has published its unaudited financial results for the third quarter (October–December 2025) and the nine months ended December 31, 2025, in newspapers, as required under SEBI listing rules. This is a routine regulatory disclosure confirming that the quarterly results already filed with the exchange have also been published in print media for public information. No new financial numbers or performance details are disclosed in this particular filing — investors need to refer to the company's earlier results filing or the newspaper notice for the actual figures.
This is a procedural filing and is unlikely to have any direct impact on the stock price. It does confirm that the company's Q3 FY26 results have been formally published, and shareholders should review the detailed results for any meaningful business updates.